AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
AMLODIPINE + VALSARTAN
135 registrations across 11 African markets— 86 active
Markets with AMLODIPINE + VALSARTAN
🇹🇳Tunisia
31 registrations
0 active
🇨🇮Côte d'Ivoire
29 registrations
11 active
🇸🇳Senegal
20 registrations
20 active
🇺🇬Uganda
16 registrations
16 active
🇲🇦Morocco
12 registrations
12 active
🇲🇬Madagascar
6 registrations
6 active
🇰🇪Kenya
6 registrations
6 active
🇬🇭Ghana
6 registrations
6 active
🇷🇼Rwanda
4 registrations
4 active
🇿🇼Zimbabwe
3 registrations
3 active
🇿🇲Zambia
2 registrations
2 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Exforge tablets 10/160mg Coated Tablet | 🇰🇪Kenya | Novartis Pharma Services Inc | active | Mar 2031 |
| Exforge tablets 5/160mg Coated Tablet | 🇰🇪Kenya | Novartis Pharma Services Inc | active | Mar 2031 |
| Amva Denk 5/80 mg Film-Coated Tablet | 🇰🇪Kenya | Denk Pharma GmbH & Co. KG | active | Sept 2030 |
| Exforge 5/80mg Tablets Film Coated Tablets | 🇿🇲Zambia | Novartis Pharma Services | active | Dec 2029 |
| VALVASC 10/160 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS LTD | active | Aug 2029 |
| VALVASC 5/160 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS LTD | active | Aug 2029 |
| AMVA DENK 5/160MG Film Coated Tablets | 🇷🇼Rwanda | BALKAN PHARMA DUPNITSA AD | active | Jul 2029 |
| AMVA DENK 10/160MG FILM COATED TABLET | 🇷🇼Rwanda | BALKAN PHARMA DUPNITSA AD | active | Jul 2029 |
| Valvasc 5/160 FC Tablets Tablets+ Filmcoated | 🇿🇲Zambia | Innovata Pharmaceuticals (Pty) Ltd | active | Jun 2029 |
| Extor Tablets 5+80 Tablet | 🇰🇪Kenya | THE SEARLE COMPANY LIMITED | active | Feb 2029 |
| EXVAL -A 80MG TABLETS (Each film coated tablet contains Amlodipine /Valsartan | 🇬🇭Ghana | — | active | Dec 2028 |
| EXVAL -A 5 / 160MG TABLETS (Each film coated tablet contains Amlodipine /Valsartan | 🇬🇭Ghana | — | active | Dec 2028 |
| EXVAL -A 10 / 160MG TABLETS (Each film coated tablet contains Amlodipine /Valsartan | 🇬🇭Ghana | — | active | Dec 2028 |
| EXVAL -A 5 / 160MG TABLETS (Each film coated tablet contains Amlodipine /Valsartan | 🇬🇭Ghana | — | active | Dec 2028 |
| EXVAL -A 10 / 160MG TABLETS (Each film coated tablet contains Amlodipine /Valsartan | 🇬🇭Ghana | — | active | Dec 2028 |
| EXVAL -A 80MG TABLETS (Each film coated tablet contains Amlodipine /Valsartan | 🇬🇭Ghana | — | active | Dec 2028 |
| Amva Denk 10/160 mg Film-Coated Tablet | 🇰🇪Kenya | DENK PHARMA GmbH & Co. KG | active | Aug 2028 |
| Amva Denk 5/160 mg Film-Coated Tablet | 🇰🇪Kenya | Denk Pharma GmbH & Co. KG | active | Aug 2028 |
| AMLODIPINE/VALSARTAN BIOGARAN 10MG/160MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | BIOGARAN | active | Apr 2028 |
| AMLODIPINE/VALSARTAN BIOGARAN 5MG/80MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | BIOGARAN | active | Apr 2028 |
| AMLODIPINE/VALSARTAN BIOGARAN 5MG/160MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | BIOGARAN | active | Apr 2028 |
| AMLODIPINE/VALSARTAN BIOGARAN 5MG/160MG COMPRIME PELLICULE BOITE DE 90 | 🇨🇮Côte d'Ivoire | BIOGARAN | active | Apr 2028 |
| AMLODIPINE/VALSARTAN BIOGARAN 10MG/160MG COMPRIME PELLICULE BOITE DE 90 | 🇨🇮Côte d'Ivoire | BIOGARAN | active | Apr 2028 |
| AMLODIPINE/VALSARTAN BIOGARAN 5MG/80MG COMPRIME PELLICULE BOITE DE 90 | 🇨🇮Côte d'Ivoire | BIOGARAN | active | Apr 2028 |
| VALEMBIC TABLET, COATED; ORAL | 🇿🇼Zimbabwe | ALEMBIC PHARMACEUTICALS LIMITED | active | Dec 2027 |
| SARTEX 5MG/160MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | EXPHA LTD | active | Dec 2027 |
| SARTEX 10MG/160MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | EXPHA LTD | active | Dec 2027 |
| EXFORGE 5MG/160MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | NOVARTIS COTE D'IVOIRESASU | active | Jun 2027 |
| EXFORGE 10MG/160MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | NOVARTIS COTE D'IVOIRESASU | active | Jun 2027 |
| EXFORGE 5MG/80MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | NOVARTIS COTE D'IVOIRESASU | active | Jun 2027 |
| EXFORGE-10/160 | 🇷🇼Rwanda | — | active | Aug 2026 |
| EXFORGE-5/160 | 🇷🇼Rwanda | — | active | Aug 2026 |
| AMVA DENK 10MG/160MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | DENK PHARMA GMBH & CO. KG | expired | Jan 2026 |
| AMVA DENK 5MG/160MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | DENK PHARMA GMBH & CO. KG | expired | Jan 2026 |
| LASTAVIN AM 5MG/80MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | AJANTA PHARMA | expired | Oct 2024 |
| LASTAVIN AM 5MG/160MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | AJANTA PHARMA | expired | Oct 2024 |
| LASTAVIN AM 10MG/160MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | AJANTA PHARMA | expired | Oct 2024 |
| AMLODAC VL 5MG/80MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | ZYDUS LIFESCIENCES LIMITED | expired | Feb 2024 |
| AMLODAC VL 10MG/160MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | ZYDUS LIFESCIENCES LIMITED | expired | Feb 2024 |
| AMLODAC VL 5MG/160MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | ZYDUS LIFESCIENCES LIMITED | expired | Feb 2024 |
| SENERGY 5MG/160MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | MS PHARMA | expired | Jan 2024 |
| AMLOVAL 10MG/160MG COMPRIME BOITE DE 28 | 🇨🇮Côte d'Ivoire | DANEEN PHARMA (PVT) LTD | expired | Jan 2023 |
| AMLOVAL 5MG/160MG COMPRIME BOITE DE 28 | 🇨🇮Côte d'Ivoire | DANEEN PHARMA (PVT) LTD | expired | Jan 2023 |
| AMLOVAL 5MG/80MG COMPRIME BOITE DE 28 | 🇨🇮Côte d'Ivoire | DANEEN PHARMA (PVT) LTD | expired | Jan 2023 |
| ICATENS Comprimé pelliculé / 5 MG/160MG | 🇹🇳Tunisia | GALPHARMA | expired | Sept 2021 |
| ICATENS Comprimé pelliculé / 10MG/160MG | 🇹🇳Tunisia | GALPHARMA | expired | Sept 2021 |
| AMVA DENK 5MG/80MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | DENK PHARMA GMBH & CO. KG | expired | Jan 2021 |
| SENERGY 10MG/160MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | MS PHARMA | expired | Jan 2021 |
| EXVALS 10MG/160MG COMPRIME BOITE DE 28 | 🇨🇮Côte d'Ivoire | PHARMACEUTICAL INSTITUTE | expired | Jan 2021 |
| AMSTAN 5MG/80MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | SCILIFE PHARMA (PRIVATE) LIMITED | expired | Jan 2021 |
Showing 50 of 135 registrations. Sign up free to search and export all.
AMLODIPINE + VALSARTAN in Africa — Regulatory Overview
AMLODIPINE + VALSARTAN is registered across 11 African markets with 135 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Côte d'Ivoire, Senegal, Uganda and 7 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 135 registrations, 86 (64%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.